When facing kidney cancer, expertise and focused care are paramount. Hans Hammers, M.D., Ph.D., affectionately known by many patients as “Doctor Hammer,” is a leading medical oncologist specializing in kidney cancer at UT Southwestern in Dallas. His national and international recognition stems from his deep dedication to advancing kidney cancer treatment and providing patients with access to the most innovative options available.
Dr. Hammer’s journey in oncology includes a fellowship at Johns Hopkins School of Medicine, where he later became a faculty member in 2009. During his tenure at Johns Hopkins, he spearheaded the kidney cancer medical oncology program until mid-2016, significantly expanding its reach and contributing groundbreaking research, particularly in the realm of immunotherapy. This experience solidified his reputation as a “doctor hammer” against kidney cancer, relentlessly fighting for patient well-being.
What sets “Doctor Hammer” apart is his unwavering commitment to kidney cancer. Unlike general oncologists who may encounter a few kidney cancer cases annually, Dr. Hammer dedicates his practice exclusively to this complex disease. This focused approach ensures patients benefit from a specialist with profound knowledge and experience in the latest kidney cancer treatments and research.
In his Dallas clinic, Dr. Hammer prioritizes patients and their families, creating a compassionate and supportive environment while delivering cutting-edge care. He believes in treating each patient with the same level of care and consideration he would expect for his own loved ones. This patient-centric philosophy is a cornerstone of his practice.
Immunotherapy: Dr. Hammer’s Game-Changing Approach
Dr. Hammer is not only a dedicated clinician but also a globally recognized thought leader in immunotherapy. This revolutionary treatment approach harnesses the body’s immune system to combat cancer, and it has dramatically transformed the landscape of kidney cancer therapy. His ongoing research aims to further refine and expand the application of innovative immunotherapies for kidney cancer patients at UT Southwestern.
“Immunotherapy offers the promise of a cure. It’s truly a game changer in oncology, and UT Southwestern is at the forefront of developing these new treatments for kidney cancer patients,” says Dr. Hammer. As “Doctor Hammer,” he is committed to wielding the most powerful tools, including immunotherapy, to fight kidney cancer and improve patient outcomes.
